Author Archives: Executive Table

Thoughts about Draft Guidance and NDI Notifications

Posted on January 10, 2012 by Executive Table

Alcrea Health believes in the principles behind the Draft Guidance—namely, ensuring consumer safety. However, we question why, after 17 years, FDA has published such stringent guidelines.  We do not believe that a consumer safety crisis exists to justify such action. … Continue reading →

Posted in Industry, News, Regulations | Leave a comment

Alcrea Health Executive Response to Multivitamin and Vitamin E Studies

Posted on October 28, 2011 by Executive Table

Two recently published scientific articles have been picked up by the mainstream press and are being used to cast a negative light on dietary supplements. We would like to briefly explain the two studies and help to put their findings … Continue reading →

Posted in News | Leave a comment